NinePointTwo Capital
- SEC CIK
- 0001824516
- Latest filing
- Feb 14, 2024
ITOS holding history
iTeos Therapeutics, Inc. in every 13F filed by NinePointTwo Capital, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ITOS overviewAll 13F holders of ITOSFull Q4 2023 holdings
- Shares (Q4 2023)
- 17,677
- Value
- $193.0K
- % of portfolio
- 0.1%
- Quarters held
- 7
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 17,677 | $193.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 17,677 | $193.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 17,677 | $234.0K | 0.1% | −1,833−9.4% | Reduced | Holders |
| Q1 2023 | 19,510 | $265.0K | 0.1% | +19,510 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −15,773−100.0% | Sold out | Holders |
| Q3 2022 | 15,773 | $300.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 15,773 | $324.0K | 0.1% | +5,095+47.7% | Added | Holders |
| Q1 2022 | 10,678 | $343.0K | 0.1% | +10,678 | New | Holders |